A UK study in the journal Anticancer Research has found that cannabis derived compounds kill cancer cells in leukemia patients.
Published last October, the findings indicate that certain non-psychoactive cannabinoids “caused a simultaneous arrest at all phases of the cell cycle… [and] resulted in dramatic reductions in cell viability,” according to the abstract of the study.
Researchers grew leukemia cells in a lab and cultured them with increasing doses of six cannabinoids, including CBD (Cannabidiol), CBDA (Cannabidiolic acid), CBG (Cannbigerol), CBGA (Cannabigerolic acid), CBGV (Cannabigevarin) and CBGVA (Cannabigevaric acid).
The cannabinoids were tested individually as well as within groups to see if they were effective at killing or stopping the growth of the cancer cells.